Iothalamate sodium
(WCIMWHNSWLLELS-UHFFFAOYSA-M)
Structure
- SMILES
- CNC(=O)c1c(I)c(NC(=O)C)c(c(c1I)C(=O)[O-])I.[Na+]
- Molecular Formula:
- C11H8I3N2NaO4
- Molecular Weight:
- 635.895
- Log P:
- 1.6458
- Hydrogen Bond Acceptor:
- 6
- Hydrogen Bond Donor:
- 2
- TPSA:
- 98.33
- CAS Number(s):
- 1225-20-3
Synonym(s)
1.
Iothalamate sodium
2.
Sodium;N-[3-carboxy-2,4,6-triiodo-5-(methylcarbamoyl)phenyl]ethanimidate
External Link(s)
| PubChem Compound | 101686454 23667529 |
| CHEMBL | CHEMBL1097620 |
| KEGG | dr:D03603 |
| Therapeutic Target Database | D02KCV |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Accidental exposure | FAERS: 1 | US FAERS | |
| 2 | Abdominal Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 3 | Agitation | Canada Vigilance: 1 | Canada Vigilance | |
| 4 | Anaphylactic shock | Canada Vigilance: 2 | Canada Vigilance | |
| 5 | Anaphylactoid Reaction | Canada Vigilance: 9 | Canada Vigilance | |
| 6 | Angina Pectoris | Canada Vigilance: 1 | Canada Vigilance | |
| 7 | Angioedema | Canada Vigilance: 1 | Canada Vigilance | |
| 8 | Anxiety | Canada Vigilance: 1 | Canada Vigilance | |
| 9 | Bradycardia | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Bronchospasm | Canada Vigilance: 3 | Canada Vigilance | |
| 11 | Cardiac Arrest | Canada Vigilance: 3 | Canada Vigilance | |
| 12 | Chest Pain | Canada Vigilance: 3 | Canada Vigilance | |
| 13 | Chills | Canada Vigilance: 5 | Canada Vigilance | |
| 14 | Cyanosis | Canada Vigilance: 2 | Canada Vigilance | |
| 15 | Dizziness | Canada Vigilance: 1 | Canada Vigilance | |
| 16 | Erythema | Canada Vigilance: 5 | Canada Vigilance | |
| 17 | Flushing | Canada Vigilance: 8 | Canada Vigilance | |
| 18 | Hypersensitivity | Canada Vigilance: 2 | Canada Vigilance | |
| 19 | Hyperventilation | Canada Vigilance: 1 | Canada Vigilance | |
| 20 | Hypotension | Canada Vigilance: 8 | Canada Vigilance | |
| 21 | Injection site pain | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Laryngospasm | Canada Vigilance: 4 | Canada Vigilance | |
| 23 | Lip swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 24 | Myalgia | Canada Vigilance: 1 | Canada Vigilance | |
| 25 | Nausea | Canada Vigilance: 7 | Canada Vigilance | |
| 26 | Pneumonitis | Canada Vigilance: 1 | Canada Vigilance | |
| 27 | Pruritus | Canada Vigilance: 6 | Canada Vigilance | |
| 28 | Rash erythematous | Canada Vigilance: 3 | Canada Vigilance | |
| 29 | Respiratory arrest | Canada Vigilance: 2 | Canada Vigilance | |
| 30 | Respiratory distress | Canada Vigilance: 1 | Canada Vigilance | |
| 31 | Rhinitis | Canada Vigilance: 1 | Canada Vigilance | |
| 32 | Sneezing | Canada Vigilance: 10 | Canada Vigilance | |
| 33 | Tachycardia | Canada Vigilance: 1 | Canada Vigilance | |
| 34 | Tremor | Canada Vigilance: 1 | Canada Vigilance | |
| 35 | Urticaria | Canada Vigilance: 53 | Canada Vigilance | |
| 36 | Vasospasm | Canada Vigilance: 1 | Canada Vigilance | |
| 37 | Vomiting | Canada Vigilance: 8 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.